![Amit Munshi](https://enterprisetherapeutics.com/wp-content/uploads/2019/03/Amit-Munshi.jpg)
Amit Munshi
Amit Munshi was most recently President and CEO of Arena Pharmaceuticals Inc. (Nasdaq:ARNA). He assumed the helm in 2016 and led the $300m market cap company through a turnaround process More...
![Dr John Ford](https://enterprisetherapeutics.com/wp-content/uploads/2018/07/John-Ford.jpg)
Dr John Ford
John has more than 20 years’ experience building innovative and successful biotechnology companies. He co-founded Xention (CSO), Ario Pharma (CEO) and Metrion Biosciences (co-owner). More...
![Dr Peter Finan](https://enterprisetherapeutics.com/wp-content/uploads/2018/10/Peter-finan-new-3-1.jpg)
Dr Peter Finan
Pete Finan joined Epidarex in 2014. He has more than 20 years of experience in drug discovery within the pharmaceutical industry. More...
![Bart Dzikowski](https://enterprisetherapeutics.com/wp-content/uploads/2020/01/Bart-Dzikowski-.jpg)
Bart Dzikowski
Bart Dzikowski is a Managing Director at the Novartis Venture Fund and its Head of Transactions & Legal based in Basel, Switzerland. He currently serves on the boards of Enterprise Therapeutics Holdings, More...
![Dr Alex Mayweg](https://enterprisetherapeutics.com/wp-content/uploads/2018/09/Alex-Mayweg-1.jpg)
Dr Alex Mayweg
Alex is a Partner at Versant. Alex is an accomplished leader in pharmaceutical drug discovery and medicinal chemistry across Europe, the U.S. and Asia. More...
![Dr Geert-Jan Mulder MD](https://enterprisetherapeutics.com/wp-content/uploads/2018/05/Gert_Jan_Mulder_Enterprise_Therapeautics.jpg)
Dr Geert-Jan Mulder MD
Geert-Jan Mulder co-founded Forbion in 2006 and serves as a Managing Partner for the fund and a Director on the board of ARMGO Pharma. Geert-Jan is an experienced life sciences investor More...
![Craig Richardson](https://enterprisetherapeutics.com/wp-content/uploads/2023/06/Craig_Richardson-300x212.png)
Craig Richardson
Craig Richardson is a Partner in IP Group’s Life Science investment team. He started his career in the pharmaceutical industry in 1998 and worked in new product development for Glaxo Wellcome, More...
![Dr Rob Woodman](https://enterprisetherapeutics.com/wp-content/uploads/2024/06/rob.png)
Dr Rob Woodman
Leading the Biotech team at Panakes Partners since 2021, Rob has global experience in biotech and pharma More...
![Dr Janet Hammond](https://enterprisetherapeutics.com/wp-content/uploads/2024/06/Janet.png)
Dr Janet Hammond
Dr Janet Hammond has over 20 years’ experience in the pharmaceutical industry, during which time she has overseen the development and successful approval of several drugs More...